TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24195796

Group type: EXPERIMENTAL
Intervention: Intraoral irradiation with 660 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extraoral irradiation with 660 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intraoral irradiation with 808 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extraoral irradiation with 808 nm laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: No irradiation
Number of subjects: 60
Study: 21130544

Group type: EXPERIMENTAL
Intervention: Infant formula containing canola oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Infant formula without canola oil (control)
Number of subjects: 0
Study: 18671297

Group type: EXPERIMENTAL
Intervention: PTNS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 30
Study: 16554400

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Meta-analysis of suitable studies
Number of subjects: 24
Study: 15180667

Group type: EXPERIMENTAL
Intervention: Three-level hierarchical mixed model
Number of subjects: 0
Study: 11774933

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg tablet dissolved in water)
Number of subjects: 8
Study: 9269706

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg/day fixed dose or titrated up to 40 mg/day)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control
Number of subjects: 153
Study: 8003922

Group type: EXPERIMENTAL
Intervention: Temporal/Parietal Junction (T/P) lesions
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inferior Parietal Lobe (IPL) lesions
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 16
Study: 3501644

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 30028241

Group type: EXPERIMENTAL
Intervention: Self-selected intensity exercise
Number of subjects: 53

Group type: COMPARATOR
Intervention: Prescribed intensity exercise
Number of subjects: 53
Study: 27388815

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 185

Group type: COMPARATOR
Intervention: Computed Tomography (CT) guidance
Number of subjects: 185
Study: 24749812

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 22271480

Group type: EXPERIMENTAL
Intervention: Two cycles of escalated BEACOPP followed by two cycles of ABVD (2 + 2)
Number of subjects: 1528

Group type: COMPARATOR
Intervention: Four cycles of ABVD
Number of subjects: 1528
Study: 20486463

Group type: EXPERIMENTAL
Intervention: Liquor carbonis distillate (LCD) solution 15%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcipotriene cream 0.005%
Number of subjects: 0
Study: 18852661

Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Number of subjects: 0
Study: 16061591

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg per day for 1 week)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 12352275

Group type: EXPERIMENTAL
Intervention: 200 mg/day hydroxychloroquine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Open treatment with hydroxychloroquine
Number of subjects: 61
Study: 10079451

Group type: EXPERIMENTAL
Intervention: 4.1 mm BENT scleral incision
Number of subjects: 29

Group type: COMPARATOR
Intervention: 4.1 mm plus meridian corneal incision (PMCI)
Number of subjects: 29
Study: 8616476

Group type: EXPERIMENTAL
Intervention: Cytokeratin-19 serum levels in NSCLC patients
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cytokeratin-19 serum levels in healthy volunteers
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Cytokeratin-19 serum levels in NSCLC patients by disease stage
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Cytokeratin-19 serum levels in NSCLC patients by performance status
Number of subjects: 116
Study: 1620909

Group type: EXPERIMENTAL
Intervention: Palpation method by inexperienced reader
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Pen method by inexperienced reader
Number of subjects: 539

Group type: COMPARATOR
Intervention: Palpation method by experienced reader
Number of subjects: 539

Group type: COMPARATOR
Intervention: Pen method by experienced reader
Number of subjects: 539
Study: 6367245

Group type: EXPERIMENTAL
Intervention: acebutolol (400 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: prazosin (4 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of prazosin and acebutolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study: 30481269

Group type: EXPERIMENTAL
Intervention: Trivalent, Russian-backbone, live, attenuated influenza vaccine (LAIV)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 29946855

Group type: EXPERIMENTAL
Intervention: Low-risk non-survivors (LN)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-risk survivors (LS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: High-risk non-survivors (HN)
Number of subjects: 48

Group type: COMPARATOR
Intervention: High-risk survivors (HS)
Number of subjects: 48
Study: 24118165

Group type: EXPERIMENTAL
Intervention: Active magnetic stimulation (25-min sessions, twice a week, 560 mT peak at 10 Hz)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Sham stimulation (5-s 'on'-5-s 'off' pulsing, 20.4% intensity at 1 Hz)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Active magnetic stimulation
Number of subjects: 151

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 151
Study: 23077532

Group type: EXPERIMENTAL
Intervention: PCV7 (2-dose group)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: PCV7 (2+1-dose group)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no PCV7)
Number of subjects: 188
Study: 19721018

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet (<50% of daily calories from carbohydrates) (n = 108)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Low-fat diet (<30% of daily calories from fat) (n = 107)
Number of subjects: 215
Study: 16708233

Group type: EXPERIMENTAL
Intervention: Dorsal instrumentation (Group 1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ventral instrumentation (Group 2)
Number of subjects: 22
Study: 15224630

Group type: EXPERIMENTAL
Intervention: Budesonide aqueous nasal spray (BANS) 128 micrograms b.i.d. for 20 weeks
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 11295925

Group type: EXPERIMENTAL
Intervention: Intralesional mumps antiserum
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Intralesional Candida antiserum
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Cryotherapy (for immune individuals)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Cryotherapy (for anergic patients)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Immunotherapy (combined results)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Immunotherapy (with complete resolution)
Number of subjects: 115
Study: 9508171

Group type: EXPERIMENTAL
Intervention: ABVD plus low-dose regional (extended-field) radiation therapy (EF RT)
Number of subjects: 111

Group type: COMPARATOR
Intervention: MOPP/ABVD
Number of subjects: 111
Study: 7836219

Group type: EXPERIMENTAL
Intervention: Immersion at 32 degrees C (below thermoneutral)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Immersion at 34.5 degrees C (thermoneutral)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Immersion at 36 degrees C (above thermoneutral)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All immersion conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Air control at 28 degrees C
Number of subjects: 8
Study: 3078521

Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg daily (n = 200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Ranitidine 200 mg daily (n = 200)
Number of subjects: 400
Study: 28411330

Group type: EXPERIMENTAL
Intervention: Restorative Yoga (RY) intervention, n = 18
Number of subjects: 33

Group type: COMPARATOR
Intervention: Wait list control group, n = 15
Number of subjects: 33
Study: 28298397

Group type: EXPERIMENTAL
Intervention: Predictive model using clinical variables (age, BMI, Epworth sleepiness scale, peak troponin levels, use of calcium antagonists)
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Predictive model using clinical variables (age, BMI, blood triglycerides, peak troponin levels, Killip class ≥II)
Number of subjects: 978
Study: 25783765

Group type: EXPERIMENTAL
Intervention: Supervised exercise training (SET)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects (reference group)
Number of subjects: 20
Study: 23545907

Group type: EXPERIMENTAL
Intervention: Treatment A (salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, dioic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment B (BenzaClin®, clindamycin 1% and benzoyl peroxide 5% gel)
Number of subjects: 0
Study: 20688209

Group type: EXPERIMENTAL
Intervention: In-lab 600-mg clopidogrel loading dose
Number of subjects: 409

Group type: COMPARATOR
Intervention: Routine 6-h pre-load with 600-mg clopidogrel
Number of subjects: 409
Study: 18635268

Group type: EXPERIMENTAL
Intervention: Phosphorylcholine-coated tympanostomy tubes (TT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Uncoated tympanostomy tubes (TT)
Number of subjects: 70
Study: 16629428

Group type: EXPERIMENTAL
Intervention: Neurophysiologically based physiotherapy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combined therapy (neurophysiologically based physiotherapy and aerobic training)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no change in habits)
Number of subjects: 112
Study: 14682154

Group type: EXPERIMENTAL
Intervention: Norfloxacin (orally)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ampicillin/sulbactam (intravenously)
Number of subjects: 25
Study: 10835097

Group type: EXPERIMENTAL
Intervention: Infant massage
Number of subjects: 58

Group type: COMPARATOR
Intervention: Crib vibrator
Number of subjects: 58
Study: 9246168

Group type: EXPERIMENTAL
Intervention: Double freeze-thaw cycle (30 seconds each)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Single freeze-thaw cycle (30 seconds)
Number of subjects: 113
Study: 1430670

Group type: EXPERIMENTAL
Intervention: Imipramine (200-300 mg daily)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No drug (control group)
Number of subjects: 115
Study: 4046836

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/twice daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31183921

Group type: EXPERIMENTAL
Intervention: Eriomin 200 mg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Eriomin 400 mg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Eriomin 800 mg
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 30531444

Group type: EXPERIMENTAL
Intervention: Isoflavone (150 mg dry extract of glycine max) plus probiotics (Lactobacillus acidophilus, Lactobacillus casei, Lactococcus lactis, Bifidobacterium bifidum, and Bifidobacterium lactis)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hormone therapy (1 mg estradiol and 0.5 mg norethisterone acetate)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isoflavone (150 mg dry extract of glycine max)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 26165565

Group type: EXPERIMENTAL
Intervention: Caregiver-focused educational brochure
Number of subjects: 0
Study: 25249300

Group type: EXPERIMENTAL
Intervention: GlycA (quartiles 1 to 4)
Number of subjects: 27491

Group type: EXPERIMENTAL
Intervention: hsCRP (quartiles 1 to 4)
Number of subjects: 27491

Group type: EXPERIMENTAL
Intervention: GlycA (quartile 4 vs 1 after lipid adjustment)
Number of subjects: 27491

Group type: EXPERIMENTAL
Intervention: hsCRP (quartile 4 vs 1 after lipid adjustment)
Number of subjects: 27491

Group type: EXPERIMENTAL
Intervention: GlycA (quartile 4 vs 1 after adjustment for hsCRP)
Number of subjects: 27491

Group type: EXPERIMENTAL
Intervention: hsCRP (quartile 4 vs 1 after adjustment for GlycA)
Number of subjects: 27491
Study: 22765856

Group type: EXPERIMENTAL
Intervention: Topical diltiazem (2 mL of 2%)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerine (2 mL of 0.2%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 20331461

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation of the anterior nuclei of the thalamus
Number of subjects: 110

Group type: COMPARATOR
Intervention: No stimulation (control group)
Number of subjects: 110
Study: 17305268

Group type: EXPERIMENTAL
Intervention: Quality Indicator (QI) feedback reports
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: APN consultation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality improvement training
Number of subjects: 0
Study: 17315409

Group type: EXPERIMENTAL
Intervention: 32 mg sublingual BUP over one hour (one-day group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 32 mg sublingual BUP over three days (three-day group)
Number of subjects: 20
Study: 12411795

Group type: EXPERIMENTAL
Intervention: Tourniquet during total knee arthroplasty
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no tourniquet) during total knee arthroplasty
Number of subjects: 46
Study: 10511425

Group type: EXPERIMENTAL
Intervention: Right hemisphere stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left hemisphere stimulation
Number of subjects: 0
Study: 7779245

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 65

Group type: COMPARATOR
Intervention: Maprotiline
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 2313083

Group type: EXPERIMENTAL
Intervention: 70% ethyl alcohol with 0.5% chlorhexidine gluconate (ALC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Liquid detergent base containing 1% triclosan (TRI)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Liquid detergent base containing 4% chlorhexidine gluconate (CHG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Liquid detergent base containing 7.5% povidone‐iodine (PI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonantimicrobial liquid soap (control)
Number of subjects: 60
Study: 384025

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 31601585

Group type: EXPERIMENTAL
Intervention: Ward-based Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard fluid therapy
Number of subjects: 50
Study: 28359996

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (same device without laser emission)
Number of subjects: 40
Study: 26079842

Group type: EXPERIMENTAL
Intervention: Monthly home counseling visits by community support agents
Number of subjects: 400

Group type: COMPARATOR
Intervention: Posttest counseling alone (routine arm)
Number of subjects: 400
Study: 24004815

Group type: EXPERIMENTAL
Intervention: Online decision aid (DA)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Standard control group
Number of subjects: 585

Group type: COMPARATOR
Intervention: Three-month control group
Number of subjects: 585
Study: 20852001

Group type: EXPERIMENTAL
Intervention: Amlodipine + Valsartan + HCTZ (triple combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Valsartan + HCTZ (dual combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine + Valsartan (dual combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine + HCTZ (dual combination)
Number of subjects: 0
Study: 19828902

Group type: EXPERIMENTAL
Intervention: Green plantain-based diet (50 g/L)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Yogurt-based diet
Number of subjects: 80
Study: 16731387

Group type: EXPERIMENTAL
Intervention: Immediate placement of Frialit‐2 Synchro implants (IP) after extraction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed placement of Frialit‐2 Synchro implants (DP) after a 3‐month healing period
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both IP and DP implants
Number of subjects: 50
Study: 15319854

Group type: EXPERIMENTAL
Intervention: Enhanced risk-reduction counseling (4 sessions)
Number of subjects: 1766

Group type: EXPERIMENTAL
Intervention: Brief risk-reduction counseling (2 sessions)
Number of subjects: 1766

Group type: COMPARATOR
Intervention: Control arm (brief informational messages)
Number of subjects: 1766
Study: 11418253

Group type: EXPERIMENTAL
Intervention: Tailored office systems for preventive service delivery
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study: 9174877

Group type: EXPERIMENTAL
Intervention: 0.3% ciprofloxacin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.3% norfloxacin
Number of subjects: 30
Study: 8342439

Group type: EXPERIMENTAL
Intervention: 45 mg of immediate‐release oral morphine tablets
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 3554084

Group type: EXPERIMENTAL
Intervention: 1 mg/kg X 1 dose of metoclopramide (regimen A)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1 mg/kg X 2 doses of metoclopramide (regimen B)
Number of subjects: 42
Study: 31921133

Group type: EXPERIMENTAL
Intervention: High baseline NKp30 expression
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NK cell activation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NKp30 expression
Number of subjects: 12
Study: 30203123

Group type: COMPARATOR
Intervention: Single escalating doses of RN909 (0.3 to 6 mg/kg SC, or 1 mg/kg IV)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Multiple escalating doses of RN909 (50 to 150 mg SC)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Single doses of RN909
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Multiple doses of RN909
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Single and multiple doses of RN909
Number of subjects: 84
Study: 27600316

Group type: EXPERIMENTAL
Intervention: Patient navigator intervention consisting of 2 in-person sessions about quality performance and viewing scores for local practices; both groups received a pamphlet about health care quality.
Number of subjects: 726

Group type: COMPARATOR
Intervention: Control group receiving a pamphlet about health care quality.
Number of subjects: 726
Study: 24812901

Group type: EXPERIMENTAL
Intervention: Qiju Dihuang Pill (QDP) for 2-4 weeks
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Qiju Dihuang Pill (QDP)
Number of subjects: 163
Study: 24829661

Group type: EXPERIMENTAL
Intervention: GERD treatment prior to surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: No GERD treatment prior to surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: GERD negative patients (control group)
Number of subjects: 58
Study: 21609913

Group type: EXPERIMENTAL
Intervention: InterX® transcutaneous dynamic electrical stimulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Manual osteopathic therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 17803999

Group type: EXPERIMENTAL
Intervention: Brachial artery flow‐mediated dilation (BFMD)
Number of subjects: 132
Study: 16422847

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 2102

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2102
Study: 12451006

Group type: EXPERIMENTAL
Intervention: Renovascular disease (RVD) patients
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: RVD patients after angioplasty
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: RVD patients
Number of subjects: 75
Study: 9895062

Group type: EXPERIMENTAL
Intervention: halothane and ketorolac
Number of subjects: 200

Group type: COMPARATOR
Intervention: halothane and placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: sevoflurane and ketorolac
Number of subjects: 200

Group type: COMPARATOR
Intervention: sevoflurane and placebo
Number of subjects: 200
Study: 7546116

Group type: EXPERIMENTAL
Intervention: 8 x 8 mesh nonwoven sponge
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 13 x 13 mesh nonwoven sponge
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 19 x 8 mesh nonwoven sponge
Number of subjects: 15
Study: 2286588

Group type: EXPERIMENTAL
Intervention: co-trimoxazole/colistin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ofloxacin
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Number of subjects: 59
Study: 7225738

Group type: EXPERIMENTAL
Intervention: Rubber band ligation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Phenol injection
Number of subjects: 82
Study: 31638594

Group type: EXPERIMENTAL
Intervention: Active education via an app providing day-to-day postoperative care information
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard patient education (weekly, basic information)
Number of subjects: 213
Study: 28822654

Group type: EXPERIMENTAL
Intervention: PA-tDCS (1 mA, 2 x 5 min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: AP-tDCS (reversed polarity, 1 mA, 2 x 5 min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 15
Study: 26416253

Group type: EXPERIMENTAL
Intervention: Food-based intervention (FB)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement intervention (ONS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 110
Study: 23318529

Group type: EXPERIMENTAL
Intervention: Exercise program (resistance and aerobic modes); n=29
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care control; n=28
Number of subjects: 57
Study: 22003339

Group type: EXPERIMENTAL
Intervention: Nasal EPAP device
Number of subjects: 41